Gut microbial metabolite hyodeoxycholic acid targets the TLR4/MD2 complex to attenuate inflammation and protect against sepsis
Molecular Therapy · 2023-04 · 31 (4) · 1017-1032
DOI: 10.1016/j.ymthe.2023.01.018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Therapy, 2023-04. Verfasst von Jiaxin Li und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathophysiology, Guangdong Provincial Key Laboratory of Proteomics, School of Basic Medical Sciences, Southern Medical University, Guan…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Sepsis. Die Arbeit wurde bisher 90-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Sepsis
Abstract (Originalsprache)
Sepsis, a critical condition resulting from the systemic inflammatory response to a severe microbial infection, represents a global public health challenge. However, effective treatment or intervention to prevent and combat sepsis is still lacking. Here, we report that hyodeoxycholic acid (HDCA) has excellent anti-inflammatory properties in sepsis. We discovered that the plasma concentration of HDCA was remarkably lower in patients with sepsis and negatively correlated with the severity of the disease. Similar changes in HDCA levels in plasma and cecal content samples were observed in a mouse model of sepsis, and these changes were associated with a reduced abundance of HDCA-producing strains. Interestingly, HDCA administration significantly decreased systemic inflammatory responses, prevented organ injury, and prolonged the survival of septic mice. We demonstrated that HDCA suppressed excessive activation of inflammatory macrophages by competitively blocking lipopolysaccharide binding to the Toll-like receptor 4 (TLR4) and myeloid differentiation factor 2 receptor complex, a unique mechanism that characterizes HDCA as an endogenous inhibitor of inflammatory signaling. Additionally, we verified these findings in TLR4 knockout mice. Our study highlights the potential value of HDCA as a therapeutic molecule for sepsis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathophysiology, Guangdong Provincial Key Laboratory of Proteomics, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China; Department of Critical Care Medicine, Nanfang Hos…
- Department of Pathophysiology, Guangdong Provincial Key Laboratory of Proteomics, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China.
- Department of Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
- Department of Microbiology, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou 510515, China.
- Institute of Ecological Sciences, School of Life Sciences, South China Normal University, Guangzhou 510515, China.
- Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Zitieren
APA
Li, J., Chen, Y., Li, R., Zhang, X., Chen, T., Mei, F., Liu, R., Chen, M., Ge, Y., Hu, H., Wei, R., Chen, Z., Fan, H., Zeng, Z., Deng, Y., Luo, H., Hu, S., Cai, S., Wu, F., …, & Chen, P. (2023). Gut microbial metabolite hyodeoxycholic acid targets the TLR4/MD2 complex to attenuate inflammation and protect against sepsis. Molecular Therapy, 31(4), 1017-1032. https://doi.org/10.1016/j.ymthe.2023.01.018
Vancouver
Li J, Chen Y, Li R, Zhang X, Chen T, Mei F, et al. Gut microbial metabolite hyodeoxycholic acid targets the TLR4/MD2 complex to attenuate inflammation and protect against sepsis. Molecular Therapy. 2023;31(4):1017-1032. doi:10.1016/j.ymthe.2023.01.018
BibTeX
@article{Li2023,
author = {Li, Jiaxin and Chen, Yuqi and Li, Rui and Zhang, Xianglong and Chen, Tao and Mei, Fengyi and Liu, Ruofan and Chen, Meiling and Ge, Yue and Hu, Hongbin and Wei, Rongjuan and Chen, Zhenfeng and Fan, Hongying and Zeng, Zhenhua and Deng, Yongqiang and Luo, Haihua and Hu, Shuiwang and Cai, Shumin and Wu, Feng and Shi, Nengxian and Wang, Zhang and Zeng, Yunong and Xie, Ming and Jiang, Yong and Chen, Zhongqing and Jia, Wei and Chen, Peng},
title = {Gut microbial metabolite hyodeoxycholic acid targets the TLR4/MD2 complex to attenuate inflammation and protect against sepsis},
journal = {Molecular Therapy},
year = {2023},
volume = {31},
number = {4},
pages = {1017--1032},
doi = {10.1016/j.ymthe.2023.01.018}
}
EUVIMED